138 related articles for article (PubMed ID: 18591617)
1. Comment to: Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study. Haematologica 2008; 93:398-403.
van der Spek E; van der Griend R
Haematologica; 2008 Jul; 93(7):e57; author reply e58. PubMed ID: 18591617
[No Abstract] [Full Text] [Related]
2. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
3. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
Friedberg JW
Haematologica; 2008 Mar; 93(3):336-8. PubMed ID: 18310538
[No Abstract] [Full Text] [Related]
4. CML after treatment for lymphoid malignancy: Therapy-related CML or coincidence?
Bolaños-Meade J; Sarkodee-Adoo C; Khanwani SL
Am J Hematol; 2002 Oct; 71(2):139. PubMed ID: 12353319
[No Abstract] [Full Text] [Related]
5. Successful treatment of an aggressive non-Hodgkin's lymphoma associated with acute respiratory insufficiency using extracorporeal membrane oxygenation.
Aboud A; Marx G; Sayer H; Gummert JF
Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):173-4. PubMed ID: 18045830
[TBL] [Abstract][Full Text] [Related]
6. Primary non-hodgkin lymphoma of breast in a patient with rectal carcinoma and magnetic resonance spectroscopic examination.
Demirkan B; Balci P; Ozcan MA; Baskan Z; Alacacioglu A; Tuncel SA; Canda T; Kocdor MA; Topcu I; Undar B; Alakavuklar M
Breast; 2005 Apr; 14(2):169-74. PubMed ID: 15767190
[TBL] [Abstract][Full Text] [Related]
7. Treatment approaches and nursing considerations for non-Hodgkin's lymphoma.
Long J; Versea L
Semin Oncol Nurs; 2006 May; 22(2):97-106. PubMed ID: 16720232
[TBL] [Abstract][Full Text] [Related]
8. Primary localized stages I and II non-Hodgkin's lymphoma of the nasopharynx: a retrospective 17-year single institutional experience.
Mohammadianpanah M; Ahmadloo N; Mozaffari MA; Mosleh-Shirazi MA; Omidvari S; Mosalaei A
Ann Hematol; 2009 May; 88(5):441-7. PubMed ID: 18931844
[TBL] [Abstract][Full Text] [Related]
9. Second primary cancers: an overview.
Ng AK; Travis LB
Hematol Oncol Clin North Am; 2008 Apr; 22(2):271-89, vii. PubMed ID: 18395150
[TBL] [Abstract][Full Text] [Related]
10. Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Gobbi PG; Angrilli F; Brugiatelli M; Musto P; Federico M
Haematologica; 2008 Sep; 93(9):1335-42. PubMed ID: 18698083
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.
La Mura V; De Renzo A; Perna F; D'Agostino D; Masarone M; Romano M; Bruno S; Torella R; Persico M
J Hepatol; 2008 Oct; 49(4):557-63. PubMed ID: 18678434
[TBL] [Abstract][Full Text] [Related]
12. Late effects of Hodgkin's disease and its treatment.
Ng AK; Mauch PM
Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of lymphoma and malignant melanoma with autologous peripheral blood stem cell transplantation].
Zhong MZ; Chen FP; Qi ZH
Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):566, 569. PubMed ID: 12516406
[No Abstract] [Full Text] [Related]
14. Primary non-Hodgkin's lymphoma in the esophagus.
Zhu Q; Xu B; Xu K; Li J; Jin XL
J Dig Dis; 2008 Nov; 9(4):241-4. PubMed ID: 18959598
[TBL] [Abstract][Full Text] [Related]
15. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
[TBL] [Abstract][Full Text] [Related]
16. Treatment of low grade non-Hodgkin's lymphomas with fludarabine.
Whelan JS; Ganjoo R; Johnson PW; Rohatiner AZ; Lister TA
Leuk Lymphoma; 1993; 10 Suppl():35-7. PubMed ID: 8481668
[No Abstract] [Full Text] [Related]
17. Potential long-term toxicities should influence the choice of therapy for indolent non-Hodgkin's lymphoma.
Friedberg JW
Haematologica; 2006 Nov; 91(11):1453-5. PubMed ID: 17082005
[No Abstract] [Full Text] [Related]
18. Should we transplant indolent lymphoma?
Nabhan C
J Clin Oncol; 2005 Sep; 23(25):6263-4; author reply 6264-6. PubMed ID: 16135498
[No Abstract] [Full Text] [Related]
19. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
Callera F; Cavenaghi L; de Melo CM
Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
[TBL] [Abstract][Full Text] [Related]
20. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
Prodanovic EM; Korman NJ
J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
